Literature DB >> 15266034

Daily on-line haemodiafiltration: a pilot trial in children.

Michel Fischbach1, Joëlle Terzic, Vincent Laugel, Céline Dheu, Soraya Menouer, Pauline Helms, Angelo Livolsi.   

Abstract

BACKGROUND: Despite major improvements in paediatric dialysis over the last two decades, cardiovascular outcome is often poor. As France gives priority to kidney transplantation over dialysis, children in chronic haemodialysis are generally pre-adolescents or adolescents with long medical histories and low compliance. In them, the usual weekly schedule of dialysis is often unsuitable. We conducted a study of conversion to daily dialysis, which allowed an enhanced dialysis dose, a gentle ultrafiltration rate and achievement of dry body weight.
METHODS: In this single-centre, observational, prospective, non-randomized study, five oligoanuric dialysis patients (mean age: 13.8 +/- 3.2 years) were converted from standard on-line haemodiafiltration (S-OL-HDF) (4 h, three times/week) to daily on-line haemodiafiltration (D-OL-HDF) (3 h, six times/week). Patient selection was based on both the presence of uraemic cardiomyopathy (left ventricular hypertrophy and reduced fractional shortening) and their reduced therapeutic compliance. The D-OL-HDF parameters were the same as for the S-OL-HDF.
RESULTS: Increasing the number of sessions from three to six weekly positively impacted the weekly dialysis dose. On D-OL-HDF, mean arterial blood pressure decreased significantly (from 95 +/- 15 to 82 +/- 13 and 87 +/- 9 mmHg at 6 and 12 months, respectively). Left ventricular hypertrophy decreased and its fractional shortening improved markedly (from 26.6 +/- 17% to 31 +/- 14% and 46.6 +/- 15% at 6 and 12 months, respectively). Pre-dialytic plasma phosphorus also decreased markedly (from 1.87 +/- 0.23 to 1.43 +/- 0.22 and 1.28 +/- 0.29 mmol/l at 6 and 12 months, respectively), as did the calcium-phosphorus product. The post-dialytic recovery time disappeared and so did perception of fatigue. Fasting the day before dialysis to avoid excess weight gain (necessitating longer dialysis) disappeared. Combined with an improved appetite, these changes resulted in higher caloric and protein intake (nPCR), from 1.28 +/- 0.23 to 1.43 +/- 0.24 g/kg at 6 months, and school attendance became regular. The only pre-pubertal child included showed catch-up growth.
CONCLUSIONS: Increasing dialysis frequency to daily sessions without shortening the durations of sessions excessively allowed us to overcome the "free diet" imposed on these paediatric, very uncompliant patients. This strategy led to a reduction in blood pressure and an improvement of left ventricular size and function, normalization of pre-dialytic plasma phosphorus and improvements in general well-being and dialysis acceptance. Long-term, however, this protocol is only acceptable for the children if associated with the potential of clinical recovery allowing inscription on the kidney transplantation waiting list.

Entities:  

Mesh:

Year:  2004        PMID: 15266034     DOI: 10.1093/ndt/gfh403

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  30 in total

1.  Interdialytic weight gain in oligoanuric children and adolescents on chronic hemodialysis.

Authors:  Fabio Paglialonga; Silvia Consolo; Maria Albina Galli; Sara Testa; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2014-11-15       Impact factor: 3.714

2.  Is peritoneal dialysis still an equal option? Results of the Berlin pediatric nocturnal dialysis program.

Authors:  Julia Thumfart; Tanja Hilliger; Christina Stiny; Steffen Wagner; Uwe Querfeld; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2015-01-27       Impact factor: 3.714

Review 3.  Hemodialysis in children: general practical guidelines.

Authors:  M Fischbach; A Edefonti; C Schröder; A Watson
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

4.  Intensified and daily hemodialysis in children might improve statural growth.

Authors:  Michel Fischbach; Joëlle Terzic; Soraya Menouer; Céline Dheu; Sylvie Soskin; Agnès Helmstetter; Marie-Claire Burger
Journal:  Pediatr Nephrol       Date:  2006-08-29       Impact factor: 3.714

Review 5.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

Review 6.  Intensified hemodialysis in adults, and in children and adolescents.

Authors:  Julia Thumfart; Wolfgang Pommer; Uwe Querfeld; Dominik Müller
Journal:  Dtsch Arztebl Int       Date:  2014-04-04       Impact factor: 5.594

Review 7.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

8.  Pediatric intradialytic hypotension: recommendations from the Pediatric Continuous Renal Replacement Therapy (PCRRT) Workgroup.

Authors:  Rupesh Raina; Stephanie Lam; Hershita Raheja; Vinod Krishnappa; Daljit Hothi; Andrew Davenport; Deepa Chand; Gaurav Kapur; Franz Schaefer; Sidharth Kumar Sethi; Mignon McCulloch; Arvind Bagga; Timothy Bunchman; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2019-02-08       Impact factor: 3.714

9.  Hemodialysis in children with ventriculoperitoneal shunts: prevalence, management and outcomes.

Authors:  Elizabeth Wright; Michel Fischbach; Ariane Zaloszyc; Fabio Paglialonga; Christoph Aufricht; Stephanie Dufek; Sevcan Bakkaloğlu; Günter Klaus; Aleksandra Zurowska; Mesiha Ekim; Gema Ariceta; Tuula Holtta; Augustina Jankauskiene; Claus Peter Schmitt; Constantinos J Stefanidis; Johan Vande Walle; Karel Vondrak; Alberto Edefonti; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2015-09-19       Impact factor: 3.714

10.  Blood volume monitoring to adjust dry weight in hypertensive pediatric hemodialysis patients.

Authors:  Cengiz Candan; Lale Sever; Mahmut Civilibal; Salim Caliskan; Nil Arisoy
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.